Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LIFE-AF) (LIFE-AF)

Clinical Trial ID NCT03785418

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03785418

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003 97.28
2 Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991 22.23
3 Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006 11.78
4 Vascular risk factors and diabetic neuropathy. N Engl J Med 2005 7.69
5 C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001 5.49
6 Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol 2015 5.18
7 Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2013 4.60
8 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011 4.48
9 Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013 4.07
10 Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 2013 3.52
11 Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress. Circulation 2003 2.69
12 Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med 2006 2.45
13 Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med 2012 2.45
14 Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011 2.34
15 Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol 2014 1.97
16 Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. JACC Cardiovasc Imaging 2010 1.62
17 Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med 2010 1.50
18 Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest 2011 1.48
19 Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA 2013 1.45
20 The Effect of Lifestyle Changes on Blood Pressure Control among Hypertensive Patients. Korean J Fam Med 2017 1.39
21 Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circ Arrhythm Electrophysiol 2010 1.27
22 Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1998 1.26
23 Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 2007 1.25
24 Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol 2004 1.22
25 Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 1999 1.19
26 Targets for glycemic control. Can J Diabetes 2013 1.09
27 Fat distribution, physical activity, and cardiovascular risk factors. Med Sci Sports Exerc 1997 1.00
28 Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns. Arch Med Sci 2015 0.93
29 The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clin Transl Gastroenterol 2015 0.92
30 Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J 2017 0.91
31 Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget 2016 0.81
32 Hypertension in Canada: Past, Present, and Future. Ann Glob Health 2016 0.80
33 Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies. Pacing Clin Electrophysiol 2013 0.79
34 Strategies to promote adherence to nutritional advice in patients with chronic kidney disease: a narrative review and commentary. Int J Nephrol Renovasc Dis 2016 0.78
35 Modifiable Risk Factors and Atrial Fibrillation. Circulation 2017 0.75
36 Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise. J Am Coll Cardiol 2017 0.75
37 Adherence to the Mediterranean diet is associated with the gut microbiota pattern and gastrointestinal characteristics in an adult population. Br J Nutr 2017 0.75
38 Obesity and atrial fibrillation outcomes and risk: Increasing the weight of evidence. Heart Rhythm 2017 0.75
Next 100